PMEF
SCPH

Point72 Middle East FZE’s scPharmaceuticals SCPH Stock Holding History

Point72 Middle East FZE’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,727
Closed -$33.8K – 2014
2023
Q1 		$33.8K Buy
+3,727
New +$27.3K ﹤0.01% 1341

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Middle East FZE's SCPH Position: Q2 2023 in Review

Point72 Middle East FZE sold out of scPharmaceuticals (SCPH) in Q2 2023, closing a stake of 3,727 shares — an estimated $33.8K sold.

Point72 Middle East FZE first reported a position in SCPH in Q1 2023 and held it in 1 quarter. The position peaked at $33.8K in Q1 2023. 81 funds tracked by Wall St. Rank hold SCPH as of Q2 2023.

  • Point72 Middle East FZE reported no remaining scPharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 3,727 scPharmaceuticals shares in Q2 2023, an estimated $33.8K.
  • Point72 Middle East FZE first reported a position in scPharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's scPharmaceuticals position peaked at $33.8K in Q1 2023.
  • 81 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.